{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:27:06Z","timestamp":1772126826735,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["20150309002YY"],"award-info":[{"award-number":["20150309002YY"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.molimm.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T15:15:16Z","timestamp":1530803716000},"page":"197-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparison of rabies virus protection by single chain and leucine zipper Fv fragments cocktail derived from a monoclonal antibody cocktail"],"prefix":"10.1016","volume":"101","author":[{"given":"Hualong","family":"Xi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongge","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2018.07.003_bib0005","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants","volume":"79","author":"Bakker","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2018.07.003_bib0010","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","author":"Bakker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2018.07.003_bib0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-1759(87)90187-6","article-title":"Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay","volume":"100","author":"Beatty","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2018.07.003_bib0020","first-page":"31","article-title":"Post-exposure prophylaxis for rabies with ERIG and IDRV in children","volume":"43","author":"Behera","year":"2011","journal-title":"J. Commun. Dis."},{"key":"10.1016\/j.molimm.2018.07.003_bib0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15252\/emmm.201505986","article-title":"Development of broad\u2010spectrum human monoclonal antibodies for rabies post\u2010exposure prophylaxis","volume":"8","author":"Benedictis","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molimm.2018.07.003_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0167-7799(91)90044-I","article-title":"Single chain antibody variable regions","volume":"9","author":"Bird","year":"1991","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.molimm.2018.07.003_bib0035","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1096\/fj.12-219964","article-title":"Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans","volume":"27","author":"Both","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.molimm.2018.07.003_bib0040","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.micinf.2008.02.008","article-title":"Novel human 3-domain disulfide-stabilized antibody fragment against glycoprotein of rabies virus","volume":"10","author":"Cai","year":"2008","journal-title":"Microb. Infect."},{"key":"10.1016\/j.molimm.2018.07.003_bib0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.molimm.2012.03.015","article-title":"A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency","volume":"51","author":"Duan","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2018.07.003_bib0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.molimm.2014.01.006","article-title":"Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57","volume":"59","author":"Duan","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2018.07.003_bib0055","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","article-title":"Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin","volume":"193","author":"Goudsmit","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2018.07.003_bib0060","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull. World Health Org."},{"key":"10.1016\/j.molimm.2018.07.003_bib0065","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1128\/AAC.06179-11","article-title":"Validation of the rapid fluorescent focus inhibition test for rabies virus-neutralizing antibodies in clinical samples","volume":"56","author":"Kostense","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molimm.2018.07.003_bib0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.molimm.2015.06.027","article-title":"A novel variable antibody fragment dimerized by leucine zippers with enhanced neutralizing potency against rabies virus G protein compared to its corresponding single-chain variable antibody fragment","volume":"68","author":"Li","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2018.07.003_bib0075","article-title":"Characterization of a human antibody fragment fab and its calcium phosphate nanoparticles that inhibit rabies virus infection with vaccine","volume":"6","author":"Liu","year":"2011","journal-title":"Plos One"},{"key":"10.1016\/j.molimm.2018.07.003_bib0080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tibtech.2007.07.005","article-title":"Antibody cocktails: next-generation biopharmaceuticals with improved potency","volume":"25","author":"Logtenberg","year":"2007","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.molimm.2018.07.003_bib0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/mabs.2.1.10786","article-title":"Antibody fragments: Hope and hype","volume":"2","author":"Nelson","year":"2010","journal-title":"Mabs"},{"key":"10.1016\/j.molimm.2018.07.003_bib0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","article-title":"Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies","volume":"188","author":"Prosniak","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2018.07.003_bib0095","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.molimm.2018.07.003_bib0100","article-title":"Post-exposure treatment with anti-rabies VHH and vaccine significantly improves protection of mice from lethal rabies infection","volume":"10","author":"Sanne","year":"2016","journal-title":"Plos Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2018.07.003_bib0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3103\/S0027131410030090","article-title":"Production of a humanized Fab fragment of a neutralizing antibody against rabies virus","volume":"65","author":"Sveshnikov","year":"2010","journal-title":"Moscow Univ. Chem. Bull."},{"key":"10.1016\/j.molimm.2018.07.003_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/66c3b26f-7b78-4412-96d0-c960b8d74b50","article-title":"Phylodynamics and human-mediated dispersal of a zoonotic virus","volume":"7","author":"Talbi","year":"2011","journal-title":"Plos Pathog."},{"key":"10.1016\/j.molimm.2018.07.003_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109367","article-title":"Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice","volume":"9","author":"Terryn","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.molimm.2018.07.003_bib0120","first-page":"287","article-title":"Immunogenicity and safety of purified vero-cell rabies vaccine in severely rabies-exposed patients in China","volume":"31","author":"Wang","year":"2000","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.molimm.2018.07.003_bib0125","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1158\/0008-5472.CAN-10-1134","article-title":"Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.molimm.2018.07.003_bib0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pep.2012.08.015","article-title":"Expression, purification and characterization of a human single-chain Fv antibody fragment fused with the Fc of an IgG1 targeting a rabies antigen in Pichia pastoris","volume":"86","author":"Wang","year":"2012","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.molimm.2018.07.003_bib0135","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.biotechadv.2009.04.004","article-title":"Applications of single-chain variable fragment antibodies in therapeutics and diagnostics","volume":"27","author":"Weisser","year":"2009","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.molimm.2018.07.003_bib0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pep.2016.05.004","article-title":"Purification and on-column refolding of a single-chain antibody fragment against rabies virus glycoprotein expressed in Escherichia coli","volume":"126","author":"Xi","year":"2016","journal-title":"Protein Exp. Purif."},{"key":"10.1016\/j.molimm.2018.07.003_bib0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imlet.2017.04.001","article-title":"Engineering of a novel zipFv using leucine zipper motif against rabies virus glycoprotein G with improved protection potency in vivo","volume":"186","author":"Xi","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2018.07.003_bib0150","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00253-009-2379-8","article-title":"Production and characterization of a recombinant single-chain antibody against Hantaan virus envelop glycoprotein","volume":"86","author":"Yang","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.molimm.2018.07.003_bib0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12250-013-3321-x","article-title":"Establishment and preliminary application of a rapid fluorescent focus inhibition test (RFFIT) for rabies virus","volume":"28","author":"Yu","year":"2013","journal-title":"Virol. Sin."},{"key":"10.1016\/j.molimm.2018.07.003_bib0160","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00253-013-5351-6","article-title":"Preparation and diagnostic use of a novel recombinant single-chain antibody against rabies virus glycoprotein","volume":"98","author":"Yuan","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.molimm.2018.07.003_bib0165","first-page":"11","article-title":"Generation of human monoclonal antibody Fab fragment to rabies virus by phage display technology","volume":"17","author":"Zhang","year":"2001","journal-title":"Chin. J. Virol."},{"key":"10.1016\/j.molimm.2018.07.003_bib0170","first-page":"243","article-title":"[Construction of human phage-displayed scFv library and selection of the ScFv against rabies virus]","volume":"20","author":"Zhao","year":"2004","journal-title":"J. Cell. Mol. Immunol."},{"key":"10.1016\/j.molimm.2018.07.003_bib0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jbiotec.2009.09.022","article-title":"Selection and affinity maturation of human antibodies against rabies virus from a scFv gene library using ribosome display","volume":"144","author":"Zhao","year":"2009","journal-title":"J. Biotechnol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018305303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018305303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:33:02Z","timestamp":1758979982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589018305303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":35,"alternative-id":["S0161589018305303"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2018.07.003","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of rabies virus protection by single chain and leucine zipper Fv fragments cocktail derived from a monoclonal antibody cocktail","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}